Tibsovo 250 mg, comprimés pelliculés - 60 Swissmedic Key 69077001 Registration Holder Servier (Suisse) SA Name Tibsovo 250 mg, comprimés pelliculés Date of registration 13.06.2024 Introduction of Sequence 13.06.2024 ATC-Classification Ivosidenib (L01XX62) Revision date WHO WHO-DDD Valid until 12.06.2029 Index Therapeuticus (BSV) Show package size 60 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680690770013 Medication Code Synthetika Pharmacode Disponibility
Composition ivosidenibum 250 mg, hypromellosi acetas succinas, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, hypromellosum, E 171, lactosum monohydricum 10 mg, triacetinum, E 132, pro compresso obducto corresp. natrium max. 5.2 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Ivosidenibum 250 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 132 color. E 171 color. Hypromellosi Acetas Succinas Hypromellosum Lactose Monohydrate 10 mg Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto Silica Colloidalis Anhydrica Triacetinum
Source Data was imported : 04.07.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
